Stocky turns companies like SARTORIUS STED BIO into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. DIM.PA shows modest growth (33/100 Compounder Score) and middling value metrics (26/100), with leadership alignment at 53/100 suggesting moderate insider commitment. A balanced vulnerability profile (50/100) provides adequate financial footing, but the 34.3 forward P/E reflects elevated valuation relative to near-term earnings power, limiting margin of safety.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for SARTORIUS STED BIO:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 42/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates SARTORIUS STED BIO (DIM.PA) at 42/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. DIM.PA shows modest growth (33/100 Compounder Score) and middling value metrics (26/100), with leadership alignment at 53/100 suggesting moderate insider commitment. A balanced vulnerability profile (50/100) provides adequate fina
DIM.PA's current Stocky Verdict is 42/100, placing it in the "Cautious" band. This composite combines a 33/100 Compounder score, 53/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for SARTORIUS STED BIO yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
SARTORIUS STED BIO scores 53/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
SARTORIUS STED BIO's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to SARTORIUS STED BIO.
Sign up free and unlock the full analysis on DIM.PA — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for DIM.PA in the app.
